SCHEMBL5460950

SCHEMBL5460950

CC(C)(C)[Si](C)(C)OCCOc1ccc(C(=O)O)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
PLA2G2A P14555 1/20 0.41
CXCR2 P25025 1/20 0.41
THRB P10828 2/20 0.40
THRA P10827 1/20 0.40
PLA2G4A P47712 1/20 0.40
GSTP1 P09211 2/20 0.40
TSHR P16473 1/20 0.40
CASP1 P29466 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPC1 O15118 1/20 0.39
ATM Q13315 1/20 0.39
PPARA Q07869 1/20 0.38
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA2 P54646 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5467355 0.88 MAPT (0.41) ALDH1A1KDM4ELMNACXCR2THRB
SCHEMBL7128194 0.84 PTPN11 (0.36) ALDH1A1KDM4ELMNATSHRSMN1; SMN2
SCHEMBL30342993 0.84 ALDH1A1 (0.43) ALDH1A1KDM4ELMNAPLA2G2ATHRB
SCHEMBL3417416 0.78 KMT2A (0.54) ALDH1A1KDM4ELMNAPLA2G2ATHRB
SCHEMBL1750089 0.78 THRB (0.60) PLA2G2ATHRBTHRATSHR
SCHEMBL27170273 0.78 THRA (0.41) LMNATHRBTHRASMN1; SMN2NPC1
SCHEMBL5064568 0.77 PLA2G4A (0.46) ALDH1A1KDM4ELMNAPLA2G2ATHRB
SCHEMBL5466698 0.76 DRD4 (0.45) ALDH1A1KDM4ELMNATSHRCASP1
SCHEMBL3363843 0.76 GPR84 (0.42) KDM4ECXCR2
SCHEMBL29492898 0.75 THRB (0.64) PLA2G2ATHRBTHRATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 ALDH1A1 731/4885KDM4E 2284/4885LMNA 3721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.